Breaking News, Collaborations & Alliances

iBio Announces 3D Bioprinting Agreement

Focus on producing recombinant human collagen-based bioink for 3D bioprinted organ transplants

iBio has entered into a Master Services Agreement (MSA) with Lung Biotechnology PBC, a subsidiary of United Therapeutics, to produce recombinant human collagen (rhCollagen)-based bioink for 3D bioprinted organ transplants. iBio will collaborate with Lung Biotechnology PBC to scale-up production of rhCollagen in tobacco plants using iBio’s FastPharming System.   “We’re pleased to have been selected by United Therapeutics to help in the mission to fundamentally change access to vital organ transpl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters